A meta-analysis of the efficacy of postoperative adjuvant radiotherapy versus no radiotherapy for extrahepatic cholangiocarcinoma and gallbladder carcinoma
Authors:
Open Access
- 15 January 2020
- journal article
- review article
- Published by Springer Nature in Radiation Oncology
- Vol. 15 (1) , 1-10
Abstract
Objective: The benefit of adjuvant radiotherapy (ART) for extrahepatic cholangiocarcinoma (EHCC) and gallbladder carcinoma (GBC) is unclear, with conflicting results from nonrandomized studies. We reported a meta-analysis to determine the impact of adjuvant radiotherapy on survival. Methods: PubMed, EMBASE, Cochrane Library and CNKI databases were searched to identify clinical trials of postoperative ART versus no radiotherapy for EHCC and GBC. The obtained data were analyzed using RevMan 5.3 and Stata 14.0 statistical software. Differences between two groups were estimated by calculating the odds ratio (OR) and 95% confidence interval (CI). Results: A total of 21 clinical trials involving 1465 EHCC and GBC patients were selected according to the inclusion and exclusion criteria and included in this meta-analysis. The meta-analysis showed the following: The 5-year overall survival (OS) rate was higher in the ART group than in the no radiotherapy group (OR = 0.63; 95% CI = 0.50–0.81, p = 0.0002). The 5-year OS rate was significantly higher for those with lymph node-positive disease (OR = 0.15; 95% CI 0.07–0.35; p < 0.00001) and margin-positive disease (OR = 0.40; 95% CI 0.19–0.85; p = 0.02) in the ART group than in the no radiotherapy group. ART had a tendency to bring benefit to the 5-year OS of patients with margin-negative disease but the difference was not statistically significant (OR = 0.57, 95% CI 0.30–1,07, p = 0.08). The local recurrence rate was significantly lower in the ART group than in the no radiotherapy group (OR = 0.54; 95% CI = 0.38–0.76, p = 0.0004), and there was no significant difference in the distant metastasis rate between the two groups (OR = 1.33; 95% CI = 0.95–1.87, p = 0.10). Conclusions: A meta-analysis of the existing study results showed that compared with no radiotherapy, ART is an effective postoperative treatment for EHCC and GBC.Keywords
Funding Information
- Jiangsu Provincial Key Project (BE2018657)
- the Jiangsu Medical Innovation Team (No. CXDT-37)
- Suzhou Introduced Project of Clinical Medical Expert Team (SZYJTD201804)
This publication has 47 references indexed in Scilit:
- Is adjuvant radiotherapy needed after curative resection of extrahepatic biliary tract cancers? A systematic review with a meta-analysis of observational studiesCancer Treatment Reviews, 2012
- Prognostic factors for gallbladder cancer in the laparoscopy eraJournal of the Korean Surgical Society, 2012
- Survival Outcomes in Resected Extrahepatic Cholangiocarcinoma: Effect of Adjuvant Radiotherapy in a Surveillance, Epidemiology, and End Results AnalysisInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2011
- Adjuvant Therapy for Gallbladder Carcinoma: The Mayo Clinic ExperienceInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2009
- Radiotherapy Is Associated With Improved Survival in Adjuvant and Palliative Treatment of Extrahepatic CholangiocarcinomasInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2009
- Extrahepatic Bile Duct Adenocarcinoma: Patients at High-Risk for Local Recurrence Treated with Surgery and Adjuvant Chemoradiation Have an Equivalent Overall Survival to Patients with Standard-Risk Treated with Surgery AloneAnnals of Surgical Oncology, 2008
- Adjuvant Concurrent Chemoradiation for Adenocarcinoma of the Distal Common Bile DuctInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2007
- Predictors of Long-term Survival in Patients with Gallbladder CancerJournal of Gastrointestinal Surgery, 2006
- Magnitude of Combination Therapy of Radical Resection and External Beam Radiotherapy for Patients With Carcinomas of the Extrahepatic Bile Duct and GallbladderDigestive Diseases and Sciences, 2005
- Perihilar Cholangiocarcinoma Postoperative Radiotherapy Does Not Improve SurvivalAnnals of Surgery, 1995